
Recombinant Factor VIII
Recombinant Factor VIII is available as either short half-life (Advate) or extended half-life (Adynovate), the Pharmac-reimbursed brands.
Current usage of recombinant products for factor VIII includes:
- Previously untreated patients of undefined age for on-demand therapy.
- Previously untreated patients about to commence a prophylaxis regimen.
- Previously treated children and adults for prophylaxis and on-demand therapy.
Advate
- Available as 250, 500, 1000, and 2000 units.
- Reconstituted with 4 mL sterile water
- Obtained from: Takeda NZ Ltd
Adynovate (extended half-life rFVIII)
- Obtained from: Takeda NZ Ltd
Topic Code: 5290